Violation Tracker Industry Summary Page

Industry: 
pharmaceuticals
Penalty Total since 2000: 
$40,181,040,154
Number of Records: 
877
Note: 
The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.

Top 10 Parent CompaniesTotal Penalty $Number of Records
Pfizer$4,747,652,94780
GlaxoSmithKline$4,422,266,05833
Johnson & Johnson$4,247,989,54954
Merck$3,310,180,72866
AbbVie$3,179,357,50750
Teva Pharmaceutical Industries$2,735,261,91850
Mallinckrodt$1,755,360,97919
Eli Lilly$1,641,265,17623
Bristol-Myers Squibb$1,554,891,42034
Novartis$1,543,646,94340


Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.
Download results as CSV or XML
Company Parent Primary Offense Type Year Agency Penalty Amountsort icon
Amgen Inc. Amgen False Claims Act and related 2019 DOJ_CIVIL $24,750,000
Ortho-McNeil Pharmaceutical LLC Johnson & Johnson off-label or unapproved promotion of medical products 2010 MULTI-AG (*) $24,681,516
Biovail Pharmaceuticals Inc. Bausch Health kickbacks and bribery 2009 USAO $24,647,876
Merck & Co., Inc. Merck False Claims Act and related 2011 MA-AG $24,000,000
Purdue Pharma Purdue Pharma drug or medical equipment safety violation 2015 KY-AG $24,000,000
Pfizer, Inc. Pfizer False Claims Act and related 2018 DOJ_CIVIL $23,850,000
Roussel Uclaf S.A. Sanofi drug or medical equipment safety violation 2001 USAO $23,193,600
Mylan Laboratories Inc. Mylan False Claims Act and related 2010 TX-AG $23,000,000
Abbott Laboratories and Fournier Industrie et Sante and Laboratoires Fournier S.A. Abbott Laboratories price-fixing or anti-competitive practices 2010 MULTI-AG $22,500,000
Par Pharmaceutical Companies Inc. Endo International off-label or unapproved promotion of medical products 2013 MULTI-AG (*) $22,500,000
Genzyme Corp. Sanofi False Claims Act and related 2013 DOJ_CIVIL $22,280,000
Genzyme Corp. Sanofi False Claims Act and related 2013 MULTI-AG (*) $22,280,000
Schwarz Pharma Inc. UCB False Claims Act and related 2010 DOJ_CIVIL $22,000,000
Johnson & Johnson Johnson & Johnson Foreign Corrupt Practices Act 2011 DOJ_CRIMINAL $21,400,000
Schering-Plough Corporation Merck False Claims Act and related 2009 CA-AG $21,300,000
Novartis Pharmaceuticals Novartis False Claims Act and related 2019 IL-AG $21,280,356
Pfizer Inc. Pfizer False Claims Act and related 2002 MULTI-AG (*) $21,084,700
Shire Pharmaceuticals LLC Takeda Pharmaceutical off-label or unapproved promotion of medical products 2014 MULTI-AG (*) $20,786,034
Celgene Corp. Bristol-Myers Squibb off-label or unapproved promotion of medical products 2017 MULTI-AG (*) $20,700,000
GlaxoSmithKline plc GlaxoSmithKline kickbacks and bribery 2016 SEC $20,000,000
Jazz Pharmaceuticals Inc. Jazz Pharmaceuticals off-label or unapproved promotion of medical products 2007 USAO $20,000,000
Clovis Oncology Inc. Clovis Oncology investor protection violation 2018 SEC $20,000,000
Eli Lilly Eli Lilly off-label or unapproved promotion of medical products 2010 LA-AG $20,000,000
Sanofi-Pasteur Sanofi False Claims Act and related 2017 DOJ_CIVIL $19,868,194
Merck Merck environmental violation 2007 EPA $19,750,000
Pharmacia & Upjohn Company Inc. Pfizer kickbacks and bribery 2007 USAO $19,700,000
Bristol-Myers Squibb Bristol-Myers Squibb off-label or unapproved promotion of medical products 2016 MULTI-AG $19,500,000
Purdue Pharma Purdue Pharma off-label or unapproved promotion of medical products 2007 MULTI-AG $19,500,000
Genentech Inc. Roche off-label or unapproved promotion of medical products 2000 MULTI-AG $19,000,000
Pharmacia Corporation Pfizer False Claims Act and related 2019 IL-AG $18,960,210
Wyeth LLC Pfizer Foreign Corrupt Practices Act 2012 SEC $18,876,624
Dey, Inc. Mylan False Claims Act and related 2003 DOJ_CIVIL $18,500,000
Eli Lilly Eli Lilly off-label or unapproved promotion of medical products 2010 AR-AG $18,500,000
Eli Lilly Eli Lilly off-label or unapproved promotion of medical products 2010 MS-AG $18,500,000
Endo Pharmaceuticals Endo International False Claims Act and related 2013 TX-AG $18,170,000
Pfizer Inc. Pfizer False Claims Act and related 2013 TX-AG $18,170,000
Acclarent Inc. Johnson & Johnson False Claims Act and related 2016 DOJ_CIVIL $18,000,000
Ranbaxy Pharmaceuticals, Inc. et al. Sun Pharmaceuticals False Claims Act and related 2014 TX-AG $17,875,000
Takeda Chemical Takeda Pharmaceutical price-fixing or anti-competitive practices 2000 MULTI-AG $17,551,650
Bausch & Lomb Bausch Health price-fixing or anti-competitive practices 2001 MULTI-AG $17,500,000
KV Pharmaceutical Company KV Pharmaceutical False Claims Act and related 2011 DOJ_CIVIL $17,000,000
KV Pharmaceutical Company KV Pharmaceutical False Claims Act and related 2012 MULTI-AG (*) $17,000,000
St. Jude Medical Inc. Abbott Laboratories kickbacks and bribery 2011 DOJ_CIVIL $16,000,000
Sandoz Novartis False Claims Act and related 2009 KY-AG $16,000,000
Mallinckrodt ARD LLC Mallinckrodt kickbacks and bribery 2019 DOJ_CIVIL $15,400,000
Sanofi-Aventis U.S. LLC Sanofi employment discrimination 2010 private lawsuit-federal $15,360,000
Abbott Laboratories AbbVie price-fixing or anti-competitive practices 2005 MULTI-AG $15,350,000
Geneva Pharmaceuticals Novartis price-fixing or anti-competitive practices 2005 MULTI-AG $15,350,000
Janssen Pharmaceuticals, Inc. Johnson & Johnson off-label or unapproved promotion of medical products 2013 MA-AG $15,100,000
Pfizer H.C.P. Corporation Pfizer Foreign Corrupt Practices Act 2012 DOJ_CRIMINAL $15,000,000
Lifescan, Inc. Johnson & Johnson False Claims Act and related 2001 DOJ_CIVIL $15,000,000
Elan Corporation, plc Perrigo accounting fraud or deficiencies 2005 SEC $15,000,000
Allergan Inc. AbbVie investor protection violation 2017 SEC $15,000,000
Pharmacia & Upjohn Company LLC Pfizer kickbacks and bribery 2007 USAO $15,000,000
Abbott Laboratories AbbVie False Claims Act and related 2009 AL-AG $14,833,333
Aventis Pharmaceutical L.P. Sanofi False Claims Act and related 2009 AL-AG $14,833,333
Forest Laboratories AbbVie False Claims Act and related 2009 AL-AG $14,833,333
Shering-Plough/Warrick Companies Merck False Claims Act and related 2009 AL-AG $14,833,333
TEVA Pharmaceuticals USA Teva Pharmaceutical Industries False Claims Act and related 2009 AL-AG $14,833,333
Allergan Inc. AbbVie off-label or unapproved promotion of medical products 2010 MULTI-AG (*) $14,750,000
Aventis Pharmaceuticals Sanofi False Claims Act and related 2019 IL-AG $14,708,388
AstraZeneca AstraZeneca False Claims Act and related 2009 KY-AG $14,700,000
Pfizer Inc. Pfizer off-label or unapproved promotion of medical products 2011 FDA $14,500,000
Bristol-Myers Squibb Bristol-Myers Squibb Foreign Corrupt Practices Act 2015 SEC $14,000,000
Merck KgaA Merck KGaA (EMD) price-fixing or anti-competitive practices 2000 DOJ_ANTITRUST $14,000,000
IVAX Pharmaceuticals Teva Pharmaceutical Industries False Claims Act and related 2009 DOJ_CIVIL $14,000,000
GlaxoSmithKline GlaxoSmithKline price-fixing or anti-competitive practices 2006 MULTI-AG $14,000,000
Abbott Laboratories Abbott Laboratories False Claims Act and related 2019 IL-AG $13,747,929
AbbVie Inc. AbbVie False Claims Act and related 2019 IL-AG $13,747,929
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim off-label or unapproved promotion of medical products 2017 MULTI-AG $13,500,000
Sandoz Novartis False Claims Act and related 2013 LA-AG $13,100,000
Alere Inc. Abbott Laboratories accounting fraud or deficiencies 2017 SEC $13,023,885
Alexion Pharmaceuticals Inc. Alexion Pharmaceuticals False Claims Act and related 2019 DOJ_CIVIL $13,000,000
Eli Lilly and Co. Eli Lilly off-label or unapproved promotion of medical products 2009 ID-AG $13,000,000
Sandoz, Inc. Novartis HHS civil monetary penalties 2015 HHSOIG $12,640,000
Schering-Plough Corporation Merck benefit plan administrator violation 2012 private lawsuit-federal $12,250,000
Teva Pharmaceuticals USA Inc. Teva Pharmaceutical Industries kickbacks and bribery 2014 IL-AG (*) $12,100,000
SciClone Pharmaceuticals SciClone Pharmaceuticals Foreign Corrupt Practices Act 2016 SEC $12,000,000
Hoechst AG Sanofi price-fixing or anti-competitive practices 2003 DOJ_ANTITRUST $12,000,000
Sanofi-Aventis U.S., LLC Sanofi False Claims Act and related 2020 USAO $11,850,000
Watson/Schein Pharmaceuticals Inc. AbbVie False Claims Act and related 2011 TX-AG $11,300,000
Eisai Inc. Eisai off-label or unapproved promotion of medical products 2010 FDA $11,000,000
Dava Pharmaceuticals Inc. Endo International False Claims Act and related 2012 DOJ_CIVIL $11,000,000
Amgen, Inc. Amgen False Claims Act and related 2013 MULTI-AG $11,000,000
Bristol-Myers Squibb Bristol-Myers Squibb False Claims Act and related 2008 AL-AG $11,000,000
Dava Pharmaceuticals, Inc. Endo International False Claims Act and related 2012 MULTI-AG (*) $11,000,000
Aventis Pharmaceuticals Inc. Sanofi False Claims Act and related 2007 MULTI-AG (*) $10,645,600
Warner Chilcott PLC AbbVie False Claims Act and related 2015 MULTI-AG (*) $10,600,000
Merck & Co., Inc. Merck benefit plan administrator violation 2012 private lawsuit-federal $10,400,000
Alpharma USPD, Inc. and Purepac Pharmaceutical Co. Pfizer False Claims Act and related 2011 KY-AG $10,200,000
Biovail Corporation Bausch Health accounting fraud or deficiencies 2008 SEC $10,000,000
Boehringer Ingelheim Corp. Boehringer Ingelheim False Claims Act and related 2005 TX-AG $10,000,000
GlaxoSmithKline GlaxoSmithKline False Claims Act and related 2005 MULTI-AG (*) $10,000,000
GlaxoSmithKline GlaxoSmithKline False Claims Act and related 2012 LA-AG $10,000,000
Johnson & Johnson Johnson & Johnson False Claims Act and related 2013 LA-AG $10,000,000
SmithKline Beecham Corp. GlaxoSmithKline price-fixing or anti-competitive practices 2005 MULTI-AG $10,000,000
Teva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc. Teva Pharmaceutical Industries False Claims Act and related 2010 KY-AG $10,000,000
Johnson & Johnson Johnson & Johnson drug or medical equipment safety violation 2019 WA-AG $9,900,000
UCB Inc. UCB off-label or unapproved promotion of medical products 2011 MULTI-AG (*) $9,893,322
Medicis Pharmaceutical Corporation Bausch Health off-label or unapproved promotion of medical products 2007 DOJ_CIVIL $9,800,000
Schwarz Pharma Inc. UCB False Claims Act and related 2010 MULTI-AG (*) $9,756,164
Download results as CSV or XML